Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
285.60
-0.70 (-0.24%)
Streaming Delayed Price
Updated: 12:33 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amgen
< Previous
1
2
3
4
5
6
7
8
9
...
34
35
Next >
4 Surefire Stocks to Buy in the Next Bear Market
August 24, 2023
Not all companies struggle when economic weakness takes hold.
Via
The Motley Fool
GRI Bio Is Bringing Hope To Patients With Idiopathic Pulmonary Fibrosis And Lupus
August 24, 2023
Inflammatory diseases are chronic conditions that involve the abnormal activation of the body's immune system, leading to chronic inflammation in various organs and tissues. Two of these diseases that...
Via
Benzinga
This Is What Whales Are Betting On Amgen
August 23, 2023
Via
Benzinga
These Are the ONLY 3 Biotech Stocks to Consider in August 2023
August 21, 2023
These biotech stocks to buy represent tremendous bets and are essentially fueling innovation and portfolio growth at the same time.
Via
InvestorPlace
Peering Into Amgen's Recent Short Interest
August 21, 2023
Via
Benzinga
Is Amgen Stock a Top Buy and Hold?
August 21, 2023
The biotech checks several important boxes for long-term shareholders.
Via
The Motley Fool
Looking At Amgen's Recent Unusual Options Activity
August 17, 2023
Via
Benzinga
The Latest Analyst Ratings for Amgen
August 14, 2023
Via
Benzinga
Here's How Much You Would Have Made Owning Amgen Stock In The Last 15 Years
August 10, 2023
Via
Benzinga
The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023
August 17, 2023
This article points you to three undervalued biotech stocks that have the potential to deliver stellar returns for patient investors.
Via
InvestorPlace
Could Amgen Stock Help You Become a Millionaire?
August 16, 2023
Its pending acquisition of Horizon Therapeutics could make the company much bigger.
Via
The Motley Fool
QUALCOMM, AIG And 2 Other Stocks Insiders Are Selling
August 14, 2023
The Nasdaq 100 closed lower on Friday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Nasdaq Suffers Second Straight Week of Losses, Breaks Key Support Level As Tech Bears Return: Is This Time Different?
August 11, 2023
Via
Benzinga
Want Rising Dividend Income? Buy Amgen Stock
August 10, 2023
The drugmaker possesses a solid medicine portfolio and pipeline.
Via
The Motley Fool
Looking At Amgen's Recent Unusual Options Activity
August 09, 2023
Via
Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $400 Today
August 08, 2023
Via
Benzinga
1 Top Dividend Growth Stock to Buy on the Dip
August 05, 2023
Investors' patience will be rewarded.
Via
The Motley Fool
Looking Into Amgen's Recent Short Interest
August 04, 2023
Via
Benzinga
The 3 Best Biotech Stocks to Buy in August
August 09, 2023
Even as healthcare stocks suffer from post-pandemic fatigue, these three of the best biotech stocks to buy and ride the wave of good news.
Via
InvestorPlace
3 Biotech Stocks You’ll Regret Not Buying Soon
August 08, 2023
These top biotech stocks are must-buys with huge potential, leading the industry with high-rewards for investors.
Via
InvestorPlace
Is AbbVie Still a Good Dividend Stock to Buy?
August 08, 2023
Find out if AbbVie can overcome sinking sales of its top-selling product.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
August 07, 2023
Via
Benzinga
Longeveron Announces Key Additions To Its Leadership Team And Board As It Gears Up For Phase 2 Trials For Its Lead Drug Candidate For Several Conditions
August 07, 2023
Longeveron, Inc. (NASDAQ: LGVN) is a clinical-stage biopharmaceutical company focused on therapies for age-related and life-threatening diseases.
Via
Benzinga
Looking At Amgen's Recent Unusual Options Activity
August 01, 2023
Via
Benzinga
If You Had Invested $5,000 in Amgen in 2013, This Is How Much You Would Have Today
August 04, 2023
The pharmaceutical company has significantly enriched shareholders over the past 10 years.
Via
The Motley Fool
Amgen Raises FY23 Outlook, Discloses Brief Readout From Tarlatamab Lung Cancer, Lumakras Colorectal Cancer Studies
August 04, 2023
Amgen Inc AMGN reported Q2 FY23 sales of $6.99 billion, up 7% Y/Y, beating the consensus of $6.63 billion.
Via
Benzinga
Amgen Beats Expectations, Raises Outlook With Horizon Takeover In The Wings
August 03, 2023
The massive biotech company also beat second-quarter expectations Thursday.
Via
Investor's Business Daily
Why Is Regeneron Pharmaceuticals Moving Higher Today?
August 03, 2023
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) earned second-quarter adjusted EPS of $10.24, up 5% Y/Y, beating the $9.92 Stre
Via
Benzinga
3 Dividend Stocks That Hiked Payouts by 60% in Just 5 Years
August 03, 2023
Can these stocks keep the rate hikes coming?
Via
The Motley Fool
US Stock Futures Dip As Apple, Amazon Earnings Loom: Analyst Warns Of 'Perfectly Normal' 5% Pullback This Month
August 03, 2023
Stocks appear to be entrenched in an August swoon and it remains to be seen if big tech earnings provide a boost.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
34
35
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.